Achieve Life Sciences Inc. ACHV is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positioning the company for a high-stakes commercial launch in 2026. In …

… Lifesciences announced that its anti-smoking generic drug ‘ZDS-Varenicline’ has secured …

… a role in how the anti-smoking drug varenicline helps individuals quit the …

… a role in how the anti-smoking drug varenicline helps individuals quit the …

Ten years ago, I decided that I should stop smoking. Before this decision, I had never given it a second thought. ‘Want to step outside for another? Yes please.’ Who cared about the wind blowing in from the Urals as we huddled around a lighter? Not I. Had …

In a significant shift in Korea's smoking cessation drug market, Pfizer Korea said it decided to withdraw its once-popular anti-smoking medication, Champix (ingredient: varenicline), from the Korean market. According to the Ministry of Food and Drug …

… , 2024 (HealthDay News) -- A quit-smoking drug appears to help people drop …

Everyone’s aware of the dangers of cigarette smoking and the health benefits that can be gained by quitting. Varenicline (sold as Chantix and Champix) is the drug of choice for cigarette smoking cessation because it’s been shown to effectively prevent both …

An anti-smoking drug cytisine "that doubles your …

AN ANTI-smoking pill that could double your chances of quitting is available on the NHS from today. Supplies of the drug, called cytisine, will reach the NHS as of January 22. 1 Cytisine has a chemical structure similar to nicotine and works by dulling …